Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of INX-08189 and Verapamil in Healthy Volunteers
NCT01471704Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of BMS-986094 in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Primary endpoints: Pharmacokinetic profile of INX-08189, Pharmacokinetic profile of Verapamil at Day 12 and 1 more. Started Oct 2011; status: completed.
02
Drugs
BMS-986094
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01471704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471704.